France· FR:60127970
DUOFILM, solution pour application cutanée
A medicinal product containing acide lactique + acide salicylique, registered in France by DIFARMED (ESPAGNE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ACIDE LACTIQUE + ACIDE SALICYLIQUE
- Manufacturer
- DIFARMED (ESPAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009490055671 flacon(s) de 15 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Acide lactique + acide salicylique in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBazuka gelDiomed Developments Ltd
- GermanyClabin NPerrigo Deutschland Gmbh
- United StatesCornexPella Pharmaceuticals Co. Ltd
- SpainANTIVERRUGAS ISDIN COLODIONIsdin S.A.
- IrelandSalactol CollodionDermal Laboratories (Ireland) Limited
- PolandAcerinAflofarm Farmacja Polska Sp. z o.o.
- SwedenVerruxin 200 mg/200 mg Kutan lösningKaro Pharma AS
- CzechiaDUOFILMSTADA Arzneimittel AG, Bad Vilbel
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Duofilm, W-Tropfen
- Czechia · Duofilm
- Germany · Clabin N, Clabin Plus
- Estonia · Duofilm
- Spain · Antiverrugas, Verufil
- United Kingdom (Northern Ireland) · Bazuka, Bazuka Treatment
- Ireland · Salactol, Salatac
- Italy · Duofilm 16,7% + 15% Collodio, Verunec
- Latvia · Duofilm
- Netherlands · Duofilm
- Poland · Abe, Acerin
- Portugal · Calicida Indiano
- Romania · Duofilm
- Sweden · Verruxin
- Slovakia · Duofilm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3c663a92-ffba-4f73-a49b-ce759fea66ef GET /v1/drugs/3c663a92-ffba-4f73-a49b-ce759fea66ef?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60127970",
"date_amm": "2024-01-31",
"type_amm": "Autorisation d'importation parallèle",
"numero_ue": null,
"substance": "ACIDE LACTIQUE + ACIDE SALICYLIQUE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution pour application",
"voies_administration": "cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about acide lactique + acide salicylique.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.